
Media
Zuvius Launches Zuvitop in 100mg Inj and 50mg caps
Admin / May 16, 2015 / Zuvitop

Zuvius Launches Zuvitop in 100mg Inj and 50mg caps, used in the treatment of Cancer.
ZUVITOP-100mg (ETOPOSIDE INJECTION IP)
COMPOISTION
Each ml contains:
Etoposide IP………………. 20mg
Citric Acid IP ………………..2mg
Polysorbate 80 IP………… 80mg
Polyethylene glycol 300 IP… 650mg
Benzoyl alcohol IP …………..30 mg
Ethyl alcohol IP……………….. 30.5%v/v
Indications :
- Etoposide Injection is indicated in the management of the following neoplasms.
- Small cell lung cancer malignant lymphomas
- Acute leukemia’s… Testicular tumors.
- Bladder Cancer. Trophoblastic diseases
- Etoposide Injection are indicated in the management of the following neoplasms.
- Small cell lung cancer. Malignant lymphomas.
Packing :
Zuvitop-100mg injection vial of 5ml individually packed.
ZUVITOP-5mg (ETOPOSIDE CAPSULE IP)
COMPOISTION
Each Hard Gelatin Capsule contains:
Etoposide IP ………………………..50mg
Excipients………………………………q.s
Approved colors used in capsule shell
Indications :
Zuvitop 50 capsules are indicated in the management of the following neoplasms:
- Small cell lung cancer
- Malignant lymphomas
Packing :
Zuvitop-50mg container of 8 capsules
500 mg/5mL Single-Use Vial
1000 mg/10mL Single-Use Vial
Archives
Recent Post
- Taking the fight to the streets Zuvius Life sciences is back with the second edition of its cancer awareness drive, the Pink Street campaign.
- Zuvius Lifescience Along with YouWeCan (Yuvraj Singh's NGO) has Initiated a Nation Wide Cancer Awareness Programme Mumbai, Maharashtra , India
- Zuvius Lifesciences & Youwecan Foundations Marathon Initiative at VJTI, Mumbai
- Zuvius Lifesciences Participated in Cancer Walk Rally
- Zuvius Launched Medico Legal Contents for Doctors and clinicians at their website